Study guide

11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

Certified Wound Specialist Physician CWSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the CWSP Exam

2 Chapter 1: Integumentary Anatomy & Wound Healing Biology

1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation

3 Chapter 2: Musculoskeletal & Neurologic Anatomy

2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care

4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing

3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing

5 Chapter 4: Patient Evaluation & Vascular Diagnostics

4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment

5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment

7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy

6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment

8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents

7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen

8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound

9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care

11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading

10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting

12 Chapter 11: Surgical Closure & Healing Complications

11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

13 Chapter 12: Nutrition Therapy & Case Review

12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis

14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds

13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas

15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes

16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds

15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds

17 Chapter 16: Traumatic Wounds, Burns & Frostbite

16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite

18 Chapter 17: Surgical, Infectious & Pediatric Wounds

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care

19 Chapter 18: Reimbursement, Regulation & Documentation

18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality

20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice

19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement

11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

Key Takeaways Explain This Topic AI

Control bleeding after debridement in steps: direct pressure, calcium alginate or oxidized cellulose, silver nitrate for small vessels, topical thrombin or tranexamic acid, then electrocautery or suture ligation; minor debridement can usually proceed without stopping anticoagulants when local hemostasis is available.

Allergic contact dermatitis (a delayed type IV reaction) spreads beyond the contact area, itches, and is confirmed by patch testing read at about day 2 and day 4, while irritant dermatitis stays within the exposed area; common wound allergens include neomycin, bacitracin, fragrances, lanolin, rubber accelerators, and colophony in adhesives.

Immediate type I reactions such as anaphylaxis to chlorhexidine or latex need emergency treatment with intramuscular epinephrine, allergen removal, and documentation of the allergy.

Medical adhesive-related skin injury includes skin stripping, tension blisters, and irritant or allergic dermatitis, and it is prevented with barrier films, silicone adhesives, tension-free application, and slow, low-angle removal with adhesive removers.

Hypertrophic scars stay within the wound borders and often improve over time, whereas keloids extend beyond the original wound and recur after excision; silicone gel or sheeting and pressure therapy are first-line prevention, and intralesional triamcinolone is a mainstay of keloid treatment.

Last updated: September 2026

11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

Core Clinical Principle: Every wound treatment can cause harm. Wound specialists must prevent, recognize, and manage bleeding, allergic reactions, device and drug adverse events, and abnormal scarring, and they must document and report these events so that patients and systems learn from them.

The CWSP task list asks candidates to manage bleeding, allergic reactions, adverse events, scarring, and infection. Infection, biofilm, and systemic barriers to healing are covered in their own sections; this section focuses on the remaining complications.

  • Bleeding
  • Hemostasis Ladder After Debridement
  • Step Method Notes
  • 1 Direct pressure with elevation for 5 to 10 minutes Controls most capillary oozing

2 Hemostatic dressings : calcium alginate, oxidized regenerated cellulose, gelatin or collagen sponges Alginate calcium ions support clotting

3 Silver nitrate for pinpoint bleeders and hypergranulation Painful; stains tissue black

4 Topical thrombin, fibrin sealants, or tranexamic acid-soaked gauze Useful for diffuse oozing and malignant wounds

  • 5 Electrocautery or suture ligation For named or pulsatile vessels
  • 6 Operating room or interventional radiology For uncontrolled or arterial bleeding

Topical epinephrine-soaked gauze constricts vessels but should be avoided on ischemic digits and flaps.

Patients Taking Anticoagulants or Antiplatelet Drugs

Minor bedside debridement can usually proceed without stopping warfarin, direct oral anticoagulants, or antiplatelet agents when local hemostatic measures are ready, because stopping them raises thrombotic risk.

Check the INR for patients on warfarin before larger procedures, and coordinate interruption and bridging with the prescriber for surgical excision under anesthesia.

Use gentler methods (autolytic, enzymatic, or conservative sharp debridement) when coagulopathy is severe, such as with thrombocytopenia or liver failure.

Warning Signs of Serious Bleeding

A sentinel bleed from a groin, neck, or bypass graft wound may precede catastrophic rupture of an infected vessel or pseudoaneurysm; treat it as an emergency.

Bleeding under NPWT can be hidden in the canister; FDA safety communications describe serious bleeding and deaths, especially with anticoagulation and exposed vessels or grafts.

Friable, easily bleeding granulation can signal infection, and bleeding from a malignant wound needs palliative hemostasis planning.

Allergic and Irritant Reactions

  • Feature Irritant Contact Dermatitis Allergic Contact Dermatitis (Type IV) Immediate Hypersensitivity (Type I)
  • Mechanism Direct chemical or physical damage T-cell-mediated sensitization IgE-mediated mast cell release
  • Timing Minutes to hours; any exposed person 24 to 72 hours after exposure in a sensitized person Minutes

Appearance Erythema, burning, confined to the exposed area Itchy, weeping, vesicular eczema that spreads beyond the contact area Hives, swelling, wheeze, hypotension

Examples Exudate, adhesives, antiseptics, incontinence Neomycin, bacitracin, fragrances, lanolin, rubber accelerators, colophony in adhesives, some topical corticosteroids Chlorhexidine, latex, some antibiotics

Management Remove the irritant; barrier film Stop the allergen; topical corticosteroid; patch test Stop exposure; intramuscular epinephrine; emergency care

Patients with leg ulcers and stasis dermatitis have high rates of contact sensitization. Patch testing applies standardized allergens under occlusion, with readings at about 48 hours and again around 96 hours . Record confirmed allergies prominently, and choose fragrance-free, lanolin-free products.

Medical Adhesive-Related Skin Injury (MARSI)

Types: Epidermal stripping, tension blisters (from tape applied under stretch or over swelling), skin tears, maceration, folliculitis, and irritant or allergic dermatitis.

Prevention: Use no-sting barrier films, choose silicone adhesives for fragile skin, apply tape without tension, allow for swelling, and remove dressings slowly, low and parallel to the skin, supporting the skin and using a medical adhesive remover.

Adverse Events From Wound Therapies

  • Therapy Examples of Adverse Events
  • Compression Pressure damage, necrosis, and amputation in unrecognized arterial disease
  • Total contact casting Cast-induced ulcers, falls, and missed infection
  • NPWT Bleeding, retained foam pieces, periwound damage, infection
  • Hyperbaric oxygen Middle ear barotrauma, temporary myopia, oxygen toxicity seizures, confinement anxiety

Topical and systemic drugs Iodine absorption and thyroid effects, argyria, mafenide acidosis, drug rashes, Stevens-Johnson syndrome

Procedures Hematoma, nerve injury, infection, pain crises

When an adverse event occurs: treat the patient, stop or change the suspected cause, disclose the event honestly to the patient, document objectively, report it through the facility safety system, and report serious drug or device problems to the FDA through MedWatch . The Joint Commission considers a stage 3, stage 4, or unstageable pressure injury acquired after admission to be a sentinel event that warrants review.

Scarring

  • Feature Hypertrophic Scar Keloid
  • Borders Stays within the original wound Extends beyond the original wound
  • Timing Usually within weeks of injury Can appear months later
  • Course Often regresses partly over 1 to 2 years Rarely regresses; frequently recurs after excision

Risk factors Tension across joints, deep dermal injury, healing longer than about 3 weeks (as in burns), infection Genetic predisposition, darker skin types, ear lobes, chest, shoulders

Prevention and treatment:

Silicone gel or sheeting: First-line prevention and treatment, worn for many hours a day for at least 2 to 3 months once the wound is epithelialized.

Pressure garments: Standard after major burns, worn most of the day for many months.

Intralesional corticosteroid (triamcinolone): Mainstay for keloids and thick hypertrophic scars; may be combined with 5-fluorouracil.

Laser, cryotherapy, and surgery: Pulsed-dye or fractional laser for redness and texture; excision of keloids needs adjuvant steroid or radiation to reduce recurrence.

Contracture: Positioning, splinting, stretching, and surgical release with Z-plasty or grafts.

Sun protection: Prevents hyperpigmentation of new scars.

Mature scar reaches only about 80% of the tensile strength of uninjured skin, and chronic unstable scars carry a small risk of malignant change (Marjolin ulcer), so a scar that ulcerates repeatedly should be biopsied.

  • Clinical Traps
  • Trap 1: Stopping Anticoagulants for Minor Debridement

Stopping a direct oral anticoagulant for a bedside debridement exposes a patient with atrial fibrillation to stroke risk for little benefit. Plan local hemostasis instead.

Trap 2: Excising a Keloid Alone

Simple excision of a keloid without adjuvant treatment often leads to a larger recurrence.